SCHEMBL23309598

SCHEMBL23309598

CN(C(=O)c1cc(F)nc(F)c1F)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.49
▸ MAOB P27338 2/20 0.47
▸ LMNA P02545 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ PLAU P00749 1/20 0.42
▸ ATM Q13315 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ NR1H3 Q13133 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ KDM1A O60341 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309678 0.81 HSD17B2 (0.41) —
SCHEMBL9001638 0.73 POLB (0.75) POLBMAOBLMNAKDM4EKMT2A
SCHEMBL529884 0.73 POLB (0.64) POLBMAOBKDM4EKMT2AMAPT
SCHEMBL3837771 0.72 POLB (0.58) POLBMAOBKDM4EKMT2AMAPT
SCHEMBL3387152 0.71 KEAP1 (0.42) KDM4ETSHRGAA
SCHEMBL18816712 0.71 POLB (0.53) POLBMAOBLMNAKDM4EKMT2A
SCHEMBL18160440 0.71 POLB (0.57) POLBMAOBKDM4EKMT2AMAPT
SCHEMBL23009384 0.71 KMT2A (0.51) POLBKDM4EKMT2APLAUATM
SCHEMBL23309607 0.70 MAPT (0.49) POLBLMNAKDM4EKMT2AMAPT
SCHEMBL18160220 0.70 POLB (0.51) POLBMAOBLMNAKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL POLB 1411/4885MAOB 2341/4885LMNA 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback